Tonix Pharmaceuticals Holding Corp.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Tonix is a publicly traded biopharmaceutical company based in the U.S. (NASDAQ: TNXP) that is focused on identifying promising new product candidates and advancing them through clinical development toward regulatory approval.

Ticker:
TNXP
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
2007
Main Therapeutic Focus:
Lead Product in Development:
TNX-102 SL In late Phase 3 for the treatment of fibromyalgia for U.S. market
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
12
Speaker
photo
Chief Executive Officer
TONIX Pharmaceuticals, Inc